Last updated on July 2018

Study to Compare the Efficacy of Pristinamycin (Pyostacine ) Versus Amoxicillin in the Treatment of Acute Community Acquired Pneumonia


Brief description of study

Primary Objective:

To evaluate the clinical efficacy of pristinamycin at a dose of 2g x 2/day for 2 days then 1g x 3/day for 5 to 7 days versus amoxicillin 1g x3 /day for 7 to 9 days, 5 to 9 days after the end of treatment.

Secondary Objectives:

To evaluate the clinical efficacy in a subpopulation bacteriologically documented at inclusion and according to procalcitonin level.

To evaluate the efficacy of treatments against pneumococcus. To evaluate the rate of relapse and mortality 302 days after treatment is started.

To document failures. To collect and follow up adverse events.

Detailed Study Description

The total study duration for each patient is 1 month with a treatment period of 7 to 9 days and a follow-up period of 21 to 23 days.

Clinical Study Identifier: NCT02332577

Contact Investigators or Research Sites near you

Start Over

Trial Transparency email recommended (Toll ...

Investigational Site Number 250023
Nantes, France
  Connect »

Trial Transparency email recommended (Toll ...

Investigational Site Number 250048
Nantes, France
0.71miles
  Connect »

Trial Transparency email recommended (Toll ...

Investigational Site Number 250046
Nantes, France
1.31miles
  Connect »

Trial Transparency email recommended (Toll ...

Investigational Site Number 250044
Nantes, France
2.12miles
  Connect »

Trial Transparency email recommended (Toll ...

Investigational Site Number 250049
Haute Goulaine, France
5.91miles
  Connect »

Trial Transparency email recommended (Toll ...

Investigational Site Number 250045
La Montagne, France
6.43miles
  Connect »